drugset / Trial / NCT06574048

Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy

NCT06574048

Phase 1/2 Not yet recruiting 20 enrolled University of Nebraska
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Hyperbaric Oxygen Therapy (HBO) is routine treatment of carbon monoxide (CO) poisoning to prevent delayed neurological sequelae. This study looking to see if neurologic outcomes are improved with the addition of dexamethasone. CO poisoning can initiate a free radical mediated process that can instigate a demyelinating process resulting in long term neurological sequelae in some, but not all patients. In other demyelinating disorders, steroids are a part of first line treatment. HBO is already used for acute CO poisoning, so this pilot study will try to ascertain if the addition of steroids in concert with each hyperbaric oxygen session will yield improved outcomes.

Timeline

Start
2026-07
Primary completion
2027-07
Completion
2028-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 10 mg Intravenous